When asked if a physician felt fairly compensated, more than 55 percent responded positively, according to Medscape's 2018 Physician Compensation Report.
Author: Staff
Stryker's neurotechnology and spine division is anticipated to see growth in the first quarter of 2018, pushing the company's overall growth, according to Zacks.
Kineta Chronic Pain signed an agreement with pharmaceutical leader Genentech to develop a non-opioid chronic pain treatment, according to CNBC.
The FDA proposed steps to improve government oversight of medical devices, according to The Seattle Times.
Here are nine key notes on orthopedic and spine device companies from the past week.
Advertisement
Kevin Black, MD, is an orthopedic surgeon at Penn State Health/Milton S. Hershey (Pa.) Medical Center.
WalletHub analysts identified the best and worst places for healthcare based on three considerations: children's health and healthcare access; children's nutrition, physical activity and obesity; and children's oral health.
PeerWell unveiled a new augmented reality tool on its platform for patients recovering from spine surgery or total joint replacement.
Joint Purification Systems, an early-stage medical device company, reported a $7.8 million Series A financing round.
Johnson & Johnson reported 1.1 percent worldwide growth in the orthopedics segment for the first quarter of 2018, but believes the line will grow as the year goes on, according to the earnings call as posted in Seeking Alpha.